Zhanjun Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhanjun Wang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Chaodong Wang
Department of Neurology & Neurobiology, Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, China
3 shared publications - Fanxi Xu
Department of Neurology and Neurobiology Xuanwu Hospital of Capital Medical University, National Clinical Research Center for Geriatric Diseases Beijing China
2 shared publications - Xianling Wang
Department of Neurology and Neurobiology Xuanwu Hospital of Capital Medical University Beijing China
2 shared publications - Xu-Ying Li
Department of Neurology and Neurobiology Xuanwu Hospital of Capital Medical University Beijing China
2 shared publications - Feng Lin
Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, Fuzhou, P. R. China
1 shared publication - Guoguang Zhao
Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 24 July 2023
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 11 (11) , e2243
Multidisciplinary molecular consultation increases the diagnosis of pediatric epileptic encephalopathy and neurodevelopmental disorders
Background: Epilepsy (EP) is a common neurological disease in which 70–80% are thought to have a genetic cause. In patients with epilepsy, neurodevelopmental delay (NDD) was prevalent. Next generation of sequencing has been widely used in diagnosing EP/NDD. However, the diagnostic yield remains to be 40%–50%. Many reanalysis pipelines and software have been developed for automated reanalysis and decision making for the diseases. Nevertheless, it is a highly challenging task for smaller genetic centers or a routine pediatric practice. To address the clinical and genetic “diagnostic odyssey,” we organized a Multidisciplinary Molecular Consultation (MMC) team for molecular consultation for 202 children with EP/NDD patients referred by lower level hospitals.Methods: All the patients had undergone an aligned and sequential consultations and discussions by a “triple reanalysis” procedure by clinical, genetic specialists, and researchers.Results: Among the 202 cases for MMC, we totally identified 47 cases (23%) harboring causative variants in 24 genes and 15 chromosomal regions after the MMC. In the 15 cases with positive CNVs, 3 cases harbor the deletions or duplications in 16p11.2, and 2 cases for 1p36. The bioinformatical reanalysis revealed 47 positive cases, in which 12 (26%) were reported to be negative, VUS or incorrectly positive in pre‐MMC reports. Additionally, among 87 cases with negative cases, 4 (5%) were reported to be positive in pre‐MMC reports.Conclusion: We established a workflow allowing for a “one‐stop” collaborative assessments by experts of multiple fields and helps for correct the diagnosis of cases with falsenegative and −positive and VUS genetic reports and may have significant influences for intervention, prevention and genetic counseling of pediatric epilepsy and neurodevelopmental disorders.
- 24 July 2023
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 11 (11) , e2243
Open AccessMultidisciplinary molecular consultation increases the diagnosis of pediatric epileptic encephalopathy and neurodevelopmental disorders
Background: Epilepsy (EP) is a common neurological disease in which 70–80% are thought to have a genetic cause. In patients with epilepsy, neurodevelopmental delay (NDD) was prevalent. Next generation of sequencing has been widely used in diagnosing EP/NDD. However, the diagnostic yield remains to be 40%–50%. Many reanalysis pipelines and software have been developed for automated reanalysis and decision making for the diseases. Nevertheless, it is a highly challenging task for smaller genetic centers or a routine pediatric practice. To address the clinical and genetic “diagnostic odyssey,” we organized a Multidisciplinary Molecular Consultation (MMC) team for molecular consultation for 202 children with EP/NDD patients referred by lower level hospitals.Methods: All the patients had undergone an aligned and sequential consultations and discussions by a “triple reanalysis” procedure by clinical, genetic specialists, and researchers.Results: Among the 202 cases for MMC, we totally identified 47 cases (23%) harboring causative variants in 24 genes and 15 chromosomal regions after the MMC. In the 15 cases with positive CNVs, 3 cases harbor the deletions or duplications in 16p11.2, and 2 cases for 1p36. The bioinformatical reanalysis revealed 47 positive cases, in which 12 (26%) were reported to be negative, VUS or incorrectly positive in pre‐MMC reports. Additionally, among 87 cases with negative cases, 4 (5%) were reported to be positive in pre‐MMC reports.Conclusion: We established a workflow allowing for a “one‐stop” collaborative assessments by experts of multiple fields and helps for correct the diagnosis of cases with falsenegative and −positive and VUS genetic reports and may have significant influences for intervention, prevention and genetic counseling of pediatric epilepsy and neurodevelopmental disorders.
- Open Access
- 1 October 2021
- Published by Korean Neurological Association in Journal of Clinical Neurology
- Vol. 17 (4) , 576-578
Cervical Cord Hemorrhage in Cerebral Cavernous Malformations
Wang Z, et al. J Clin Neurol. 2021 Oct;17(4):576-578. https://doi.org/10.3988/jcn.2021.17.4.576
- 1 October 2021
- Published by Korean Neurological Association in Journal of Clinical Neurology
- Vol. 17 (4) , 576-578
Open AccessCervical Cord Hemorrhage in Cerebral Cavernous Malformations
Wang Z, et al. J Clin Neurol. 2021 Oct;17(4):576-578. https://doi.org/10.3988/jcn.2021.17.4.576
- Open Access
- 1 May 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 752, 135831
Autosomal recessive spastic ataxia of Charlevoix-Saguenay caused by novel mutations in SACS gene: A report of two Chinese families
- 1 May 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 752, 135831
Open AccessAutosomal recessive spastic ataxia of Charlevoix-Saguenay caused by novel mutations in SACS gene: A report of two Chinese families